BIOTECH ACQUISITION COMPANY Retained Earnings
BIOTECH ACQUISITION COMPANY had Retained Earnings of -$13.12 million as of 2022-09-30, per its 10-Q filed 2022-11-22.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2022-11-22
- 2022-09-30: Retained Earnings (Accumulated Deficit) -$13.12M.
- 2022-06-30: Retained Earnings (Accumulated Deficit) -$13.37M.
- 2022-03-31: Retained Earnings (Accumulated Deficit) -$22.47M.
- 2021-12-31: Retained Earnings (Accumulated Deficit) -$27.17M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2022-09-30 | -$13.12M 10-Q · filed 2022-11-22 |
| 2022-06-30 | -$13.37M 10-Q · filed 2022-08-22 |
| 2022-03-31 | -$22.47M 10-Q · filed 2022-05-16 |
| 2021-12-31 | -$27.17M 10-Q · filed 2022-11-22 |
| 2021-09-30 | -$19.88M 10-Q · filed 2021-11-17 |
| 2021-06-30 | -$2.53M 10-Q · filed 2021-08-11 |
| 2021-03-31 | $2.54M 10-Q · filed 2021-05-24 |
| 2020-12-31 | -$5.00K 10-K · filed 2022-03-08 |
| 2020-09-30 | -$5.00K 10-Q · filed 2021-03-11 |